COVID-19 MAbs should be made with combination in mind says US FDA

Retrieved on: 2021-02-26 10:41:15

Tags for this article:

Click the tags to see associated articles and topics

COVID-19 MAbs should be made with combination in mind says US FDA. View article details on hiswai:

Excerpt

Monoclonal antibody (mAb) manufacturers aiming for an EUA should ... development for manufacturing processes for anti-SARS-CoV-2 antibodies.

Article found on: bioprocessintl.com